These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

236 related items for PubMed ID: 12434960

  • 1. Parental confidence in measles, mumps and rubella vaccine: evidence from vaccine coverage and attitudinal surveys.
    Ramsay ME, Yarwood J, Lewis D, Campbell H, White JM.
    Br J Gen Pract; 2002 Nov; 52(484):912-6. PubMed ID: 12434960
    [Abstract] [Full Text] [Related]

  • 2. The two-dose measles, mumps, and rubella (MMR) immunisation schedule: factors affecting maternal intention to vaccinate.
    Pareek M, Pattison HM.
    Br J Gen Pract; 2000 Dec; 50(461):969-71. PubMed ID: 11224968
    [Abstract] [Full Text] [Related]

  • 3. Tracking mothers' attitudes to MMR immunisation 1996-2006.
    Smith A, Yarwood J, Salisbury DM.
    Vaccine; 2007 May 16; 25(20):3996-4002. PubMed ID: 17395344
    [Abstract] [Full Text] [Related]

  • 4. Why do parents hesitate to vaccinate their children against measles, mumps and rubella?
    Alfredsson R, Svensson E, Trollfors B, Borres MP.
    Acta Paediatr; 2004 Sep 16; 93(9):1232-7. PubMed ID: 15384890
    [Abstract] [Full Text] [Related]

  • 5. [Evaluation of measles, mumps and rubella vaccine coverage in 3 year old children in twelve French counties. Time-trends and related factors].
    Rotily M, Guagliardo V, Fontaine D, Garros B, Mayer C, Arrighi J, Woronoff AS, Ledesert B, Lepec R, Chabaud F, Janvrin MP, Baudier F.
    Rev Epidemiol Sante Publique; 2001 Sep 16; 49(4):331-41. PubMed ID: 11567200
    [Abstract] [Full Text] [Related]

  • 6. Parents' perspectives on the MMR immunisation: a focus group study.
    Evans M, Stoddart H, Condon L, Freeman E, Grizzell M, Mullen R.
    Br J Gen Pract; 2001 Nov 16; 51(472):904-10. PubMed ID: 11761204
    [Abstract] [Full Text] [Related]

  • 7. [Vaccinations in early infancy -- results of an epidemiological cross-sectional study in Hamburg].
    Fell G, David C, Reintjes R.
    Gesundheitswesen; 2005 Jan 16; 67(1):27-32. PubMed ID: 15672303
    [Abstract] [Full Text] [Related]

  • 8. Attitudinal and demographic predictors of measles, mumps and rubella (MMR) vaccine acceptance: development and validation of an evidence-based measurement instrument.
    Brown KF, Shanley R, Cowley NA, van Wijgerden J, Toff P, Falconer M, Ramsay M, Hudson MJ, Green J, Vincent CA, Kroll JS, Fraser G, Sevdalis N.
    Vaccine; 2011 Feb 11; 29(8):1700-9. PubMed ID: 21185850
    [Abstract] [Full Text] [Related]

  • 9. The potential for measles transmission in England.
    Choi YH, Gay N, Fraser G, Ramsay M.
    BMC Public Health; 2008 Sep 26; 8():338. PubMed ID: 18822142
    [Abstract] [Full Text] [Related]

  • 10. Immunogenicity and safety of a second dose of measles-mumps-rubella-varicella vaccine in healthy children aged 5 to 6 years.
    Vesikari T, Baer M, Willems P.
    Pediatr Infect Dis J; 2007 Feb 26; 26(2):153-8. PubMed ID: 17259879
    [Abstract] [Full Text] [Related]

  • 11. Influence of MMR-vaccinations and diseases on atopic sensitization and allergic symptoms in Swiss schoolchildren.
    Roost HP, Gassner M, Grize L, Wüthrich B, Sennhauser FH, Varonier HS, Zimmermann H, Braun-Fahrländer Ch, SCARPOL-team.
    Pediatr Allergy Immunol; 2004 Oct 26; 15(5):401-7. PubMed ID: 15482514
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Is the cultural context of MMR rejection a key to an effective public health discourse?
    Cassell JA, Leach M, Poltorak MS, Mercer CH, Iversen A, Fairhead JR.
    Public Health; 2006 Sep 26; 120(9):783-94. PubMed ID: 16828492
    [Abstract] [Full Text] [Related]

  • 15. Evaluation of the measles, mumps and rubella vaccination catch-up campaign in England in 2013.
    Simone B, Balasegaram S, Gobin M, Anderson C, Charlett A, Coole L, Maguire H, Nichols T, Rawlings C, Ramsay M, Oliver I.
    Vaccine; 2014 Aug 06; 32(36):4681-8. PubMed ID: 24996125
    [Abstract] [Full Text] [Related]

  • 16. Adolescent vaccination: coverage achieved by ages 13-15 years, and vaccinations received as recommended during ages 11-12 years, National Health Interview Survey 1997-2003.
    McCauley MM, Stokley S, Stevenson J, Fishbein DB.
    J Adolesc Health; 2008 Dec 06; 43(6):540-7. PubMed ID: 19027641
    [Abstract] [Full Text] [Related]

  • 17. Prevalence of IgG antibody against measles, mumps and rubella in bangladeshi children: a pilot study to evaluate the need for integrated vaccination strategy.
    Sultana R, Rahman MM, Hassan Z, Hassan MS.
    Scand J Immunol; 2006 Dec 06; 64(6):684-9. PubMed ID: 17083626
    [Abstract] [Full Text] [Related]

  • 18. Could the MMR vaccine replace the measles vaccine at one year of age in Egypt?
    Abbassy AA, Barakat SS, Abd El Fattah MM, Said ZN, El Metwally HA.
    East Mediterr Health J; 2009 Dec 06; 15(1):85-93. PubMed ID: 19469430
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. MMR immunisation status among Dublin paediatric A&E attenders.
    Murphy AW, Power R, Kinlen DM, Johnson Z.
    Ir Med J; 1994 Dec 06; 87(2):40-2. PubMed ID: 8194951
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.